to sprout and invade into the surrounding extracellular matrix. 8 In this model, many of the morphogenic features of sprouting angiogenesis are recapitulated, including tip cells, stalk cells, and multicellular branched networks. Here, using this system, we sought to investigate the effects of Cdc42 on the morphogenic processes of angiogenesis.
Unlike other studies of tubulogenesis and Matrigel™ assays, where endothelial cell network formation occurred in a uniform distribution of biochemical stimuli, our system employed a biochemical gradient not only to stimulate the formation of multicellular sprout structures, but also to unveil the effects of Cdc42 in the context of chemotactic migration in angiogenic sprouting. We observed that Cdc42 mediates several aspects of the morphogenetic processes of angiogenesis.
| MATERIALS AND METHODS

| Device fabrication
As previously reported, devices were fabricated from two layers of poly(dimethylsiloxane; PDMS; Sylgard 184; Dow-Corning, Midland, MI, USA), which were cast from silicon wafer masters. 8 The PDMS layers were treated with a plasma etcher (Quorum Technologies, Lewes, UK), bonded together, and adhered to a 25-mm square glass coverslip. After treatment with 0.1 mg/mL poly-L-lysine (Sigma, St. Louis, MO, USA) for 1 hour, they were treated with 1% glutaraldehyde for 1 hour and washed several times with water. Rat tail collagen type I (2.5 mg/mL, Corning Incorporated, Corning, NY, USA) solution was pipetted into the devices with two 400 μm diameter acupuncture needles (Hwato, Lhasa OMS, Weymouth, MA, USA). Upon gelation, the needles were extracted leaving two hollow cylindrical channels within the collagen matrix.
| Cell culture
HUVECs (Lonza, Allendale, NJ, USA) were cultured in EGM-2 (Lonza) up to passage 9. HUVECs were seeded into the channel at 3×10 6 cells/mL as previously described. 8 After seeding was complete, devices were immediately placed on a platform rocker (BenchRocker, BR2000, Benchmark Scientific, Edison, NJ, USA).
| Angiogenic sprouting assay
A combination of angiogenic factors including VEGF (75 ng/mL, R&D, Minneapolis, MN, USA), MCP-1 (75 ng/mL, R&D), sphingosine-1-phosphate (S1P, 500 nmol/L, Cayman Chemical, Ann Arbor, MI, USA), and PMA (10 ng/mL, Sigma) were administered the day after cell seeding. The cocktail of angiogenic factors was refreshed daily as previously described. 
| Inhibition of Cdc42 experiment
The day after cell seeding, the angiogenic cocktail of VEGF, MCP-1, S1P, and PMA was administered into the angiogenic source channel to trigger angiogenic sprouting. Simultaneously, the Cdc42 inhibitor (ML141, 15 μmol/L, Millipore, Billerica, MA, USA) was administered in both the biomimetic blood vessel and in the angiogenic source channel at the onset of sprouting. Devices were either treated with DMSO as control or ML141 over a course of 4 days before they were fixed and stained for confocal imaging. Devices were always placed on a tilting rocker to provide shear forces in the channels over the entire course of experiments. For filopodia experiment, 22.5 μmol/L ML141 was added for 4 hours before they were fixed for quantification (N=4 individual experiments).
| Immunofluorescence and confocal image acquisition
After fixation, devices were permeated with 0.1% Triton-X (Sigma, 
| Quantification of branches and intersegmental branches
Adopting the custom MATLAB code from quantification of sprouts,
we quantified the number of branches and intersegmental branches and their respective lengths. A branch length was defined as the distance from the tip of the branch to the end of the branch on the sprout, whereas intersegmental branch length was defined as the distance connecting the two ends of the intersegmental branch on two separate sprouts.
| Filopodia quantification
A custom MATLAB code was used to determine the distance from the tips of filopodia to where they originate on the cell body from projections of Z-resolved confocal stacks. The number and length of filopodia were averaged over the number of tip cells in each sample.
Filopodia angle was measured as the angles in which a filopodium deviates from the vertically perpendicular line between the two channels (N=4 individual experiments).
| Statistical analysis
Sample populations were compared using unpaired, two-tailed 
| RESULTS
| Inhibition of Cdc42 reduced 3D invasion speed of sprouts
To elucidate the role of Cdc42 in angiogenesis, we employed a biomimetic angiogenic model which we previously developed ( Figure 1A ).
Briefly, the system consists of two hollow cylindrical channels embedded within a 3D collagen matrix, which are formed by polymerizing a solution of rat tail collagen I around acupuncture needles that are later removed. In one of the channels, endothelial cells were seeded to form an endothelium. In the second channel, a cocktail of angiogenic factors was administered to establish an angiogenic gradient to trigger sprouting into the 3D collagen matrix. 8 Genetic manipulation
of Cdc42 with a dominant negative Cdc42N17 appeared to inhibit formation of a monolayer of endothelial cells with intact junctional contacts in our channel and inhibit cell migration. Therefore, to inhibit Cdc42 activity, cultures were treated with a selective pharmaceutical inhibitor of Cdc42, ML141 after monolayer formation. 10, 11 In the pilot experiments, we observed that complete inhibition of Cdc42 using high concentrations of ML141 led to rapid cell death (Fig. S1 ).
Therefore, to enable our studies, we targeted a 50% decrease in the activity of Cdc42 ( Figure 1B ). To maximize the effect of Cdc42 inhibition on sprouting morphogenesis, we administered the inhibitor at the onset of sprouting and monitored the migration of endothelial cells using phase contrast imaging over a course of 4 days. We quantified the distance traveled by invading cells into the interstitial collagen matrix and showed that partial inhibition of Cdc42 activity appeared to significantly slow down the invasion speed and migration of endothelial cells into the interstitial matrix ( Figure 1C ), suggesting that Cdc42
regulates migration speed of angiogenic sprouting.
| Inhibiting Cdc42 diminished sprout density and sprout length
To further characterize the effects of Cdc42 inhibition on sprouting, we queried whether there were observable changes to the structure of the multicellular sprouts themselves, which could not be examined under phase contrast microscopy imaging. Thus, after sprouting for 4 days, cultures with and without ML141 were fixed, stained, and im- Given that Cdc42 regulates cell polarity, and persistence of migration on 2D substrates, 10, 12 we hypothesize that inhibition of Cdc42 may reduce directional migration in a 3D collagen matrix. As a metric for directional migration, we measured the sprout angle as the deviation angle of the sprout from vertical axis between the two channels. In our model, addition of ML141 did not alter the sprout angle suggesting that directional migration was maintained ( Figure 2C) .Interestingly, the number of migrating cells significantly decreased when Cdc42 activity was antagonized ( Figure 2D ). Examining the migrating cells in the interstitial matrix, we observed a fraction of the migrating cells was single cells, and this fraction was significantly elevated when Cdc42 activity was diminished ( Figure 2E,F) . Moreover, we also observed that junctional contacts of endothelial cells were also compromised when they were exposed to the Cdc42 inhibitor (Fig. S2) . Interestingly, Cdc42
has been implicated in regulating lumen formation in endothelial cell tubulogenesis, but our data demonstrated that the percentage of lumenized sprouts remained unaffected when Cdc42 activity was partially blocked (Fig. S3) . Taken together, these data unveiled that partial inhibition of Cdc42 activity reduced the extent of cellular invasion and impaired collective cell migration during angiogenic sprouting, possibly due to compromising junctional contacts in endothelial cells.
| Cdc42 regulates branching morphogenesis of angiogenic sprouting
During angiogenesis, blood vessel branching is an important morphogenetic process to grow complex vascular networks. 2, 13 As previously reported, branching was evidenced in our 3D biomimetic angiogenic model. 8 We observed two distinct populations of branches in our model. One set of multicellular branches exhibit multicellular structures that emanate from a multicellular sprout, whereas another set of multicellular branches appear to connect two neighboring sprout structures, which we referred to as intersegmental branches Figure 3C,D) . Surprisingly, the length of both branches and intersegmental branches remained unaltered upon partial inhibition of Cdc42 activity ( Figure 3E,F) . Together this suggests that Cdc42 enables endothelial cells to initiate new branches, but does not participate in regulating extension of the branches and intersegmental branches.
| Effects of Cdc42 inhibition on filopodia formation
One possibility for how Cdc42 promotes branching is through its reported effects on filopodial formation, mostly described for cells cultured in 2D settings. [14] [15] [16] To investigate whether Cdc42 is involved in filopodial formation in 3D, we treated well developed multicellular Figure 4D ).
These changes ultimately led to a surge in the number of filopodia-like extensions. Furthermore, perturbation of Cdc42 activity also significantly reduced the length of these filopodia-like extensions ( Figure 4E) due to an upsurge in filopodia-like extensions of ~5 μm long ( Figure 4F ).
| DISCUSSION
While Cdc42 has been identified as an important regulator of many cellular processes such as control of cell division, establishment of Additionally, Cdc42 is activated by junctional proteins, P-cadherins, to mediate collective migration in mesenchymal myoblasts. 24 In an- During lung development, Cdc42 directly regulates polarity and its activity is heightened at the active budding sides. 26 Consequently, disruption of Cdc42 by genetic knockout causes abnormal Cdc42 activity on the epithelial cell layer and ultimately reduces epithelial cell budding during lung morphogenesis. 26 Similarly, in endothelial cell sprouting from an endothelium, quiescent endothelial cells first need to reverse polarity to become tip cells. 27 As a result, a disruption of polarity signaling may potentiate abnormal morphogenesis. Our result demonstrated that partial inhibition of Cdc42 activity caused a reduction in sprout density, which may suggest a role of Cdc42 
PERSPECTIVE
In conclusion, using an organotypic model of angiogenesis in which sprouting emanates from an endothelium under a defined biochemical gradient, we characterized the effects of Cdc42 on angiogenic sprouting using a pharmaceutical inhibitor of Cdc42 ML141. In our 3D angio- 
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